The Traderszone Network

Published in TZ Latest News 1 May, 2014 by The TZ Newswire Staff

Valeant Pharmaceuticals Clears Resistance Level

Most Sector Leaders put in gains Thursday amid mixed results in the general market. Valeant Pharmaceuticals (VRX) rallied 4.42, or 3%, to 138.13 in fast trade. The stock has bounced back in mostly large volume as a new base forms. But the base would be a more risky late-stage structure. The Canadian drugmaker will announce Q1 earnings before the open on Thursday. Valeant is expected to earn $1.72 a share, up 32% from a year ago.

read more